Auxiliadora Gómez‐España

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Xavier García del Muro, Antonio López–Pousa, Joan Maurel et al. · Journal of Clinical Oncology · 2011 · 298 citations

Medicine, Oncology, Pharmacotherapy +12

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España et al. · Journal of Clinical Oncology · 2007 · 269 citations · Full text

Medicine, Oncology, Pharmacology +11

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí et al. · The Oncologist · 2012 · 212 citations · Full text

Medicine, Oncology, Pharmacology +12

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Javier Sastre, M.L. Maestro, Auxiliadora Gómez‐España et al. · The Oncologist · 2012 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

Eva Martinez‐Balibrea, Albert Abad, Enrique Aranda et al. · European Journal of Cancer · 2008 · 72 citations

Medicine, Oncology, Pharmacology +17